Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ted Rosen

Showing results (91-100 of 104) with videos related to

Pageof 11
Sort By:
The Journal of Clinical and Aesthetic Dermatology|October 16, 2018
Imiquimod 2.5% and 3.75% Cream for the Treatment of Photodamage: A Meta-analysis of Efficacy and Tolerability in 969 Randomized PatientsJames Del Rosso, Neil Swanson, Brian Berman, et al.
Dermatology Online Journal|May 15, 2007
Massive nodular melanoma: a case reportMandy Harting, William Tarrant, Craig A Kovitz, et al.
Journal of Drugs in Dermatology : JDD|March 9, 2016
Onychomycosis: Strategies to Minimize RecurrenceAditya K Gupta, Boni E Elewski, Ted Rosen, et al.
Journal of the American Academy of Dermatology|July 5, 2020
Efinaconazole 10% topical solution for the treatment of onychomycosis in pediatric patients: Open-label phase 4 studyLawrence F Eichenfield, Boni Elewski, Jeffrey L Sugarman, et al.
Journal of Drugs in Dermatology : JDD|January 6, 2026
Topical Efinaconazole 10% for Onychomycosis: Pooled Phase 3 Analysis in White, Black, and Asian ParticipantsShari R Lipner, Aditya K Gupta, Tracey C Vlahovic, et al.
Journal of Drugs in Dermatology : JDD|May 12, 2016
Onychomycosis: Does Cure Equate to Treatment Success?Boni E Elewski, Aditya K Gupta, Ted Rosen, et al.
The Journal of Clinical and Aesthetic Dermatology|July 28, 2016
Status Report from the Scientific Panel on Antibiotic Use in Dermatology of the American Acne and Rosacea Society: Part 1: Antibiotic Prescribing Patterns, Sources of Antibiotic Exposure, Antibiotic Consumption and Emergence of Antibiotic Resistance, Impact of Alterations in Antibiotic Prescribing, and Clinical Sequelae of Antibiotic UseJames Q Del Rosso, Guy F Webster, Ted Rosen, et al.
American Journal of Clinical Dermatology|September 13, 2021
Phase II, Double-Blind, Vehicle-Controlled Study to Determine the Cantharidin Dose Regimen, Efficacy, Safety, and Tolerability of VP-102 in Subjects with External Genital WartsScott Guenthner, Wendy McFalda, Melita Tate, et al.
The Journal of Clinical and Aesthetic Dermatology|July 8, 2016
Status Report from the Scientific Panel on Antibiotic Use in Dermatology of the American Acne and Rosacea Society: Part 3: Current Perspectives on Skin and Soft Tissue Infections with Emphasis on Methicillin-resistant Staphylococcus aureus, Commonly Encountered Scenarios when Antibiotic Use May Not Be Needed, and Concluding Remarks on Rational Use of Antibiotics in DermatologyJames Q Del Rosso, Ted Rosen, Diane Thiboutot, et al.
Journal of Drugs in Dermatology : JDD|October 7, 2020
Safety, Pharmacokinetics, and Efficacy of Efinaconazole 10% Topical Solution for Onychomycosis Treatment in Pediatric PatientsLawrence F Eichenfield, Boni Elewski, Jeffrey L Sugarman, et al.
Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
The Journal of Clinical and Aesthetic Dermatology|October 16, 2018
Imiquimod 2.5% and 3.75% Cream for the Treatment of Photodamage: A Meta-analysis of Efficacy and Tolerability in 969 Randomized PatientsJames Del Rosso, Neil Swanson, Brian Berman, et al.
Dermatology Online Journal|May 15, 2007
Massive nodular melanoma: a case reportMandy Harting, William Tarrant, Craig A Kovitz, et al.
Journal of Drugs in Dermatology : JDD|March 9, 2016
Onychomycosis: Strategies to Minimize RecurrenceAditya K Gupta, Boni E Elewski, Ted Rosen, et al.
Journal of the American Academy of Dermatology|July 5, 2020
Efinaconazole 10% topical solution for the treatment of onychomycosis in pediatric patients: Open-label phase 4 studyLawrence F Eichenfield, Boni Elewski, Jeffrey L Sugarman, et al.
Journal of Drugs in Dermatology : JDD|January 6, 2026
Topical Efinaconazole 10% for Onychomycosis: Pooled Phase 3 Analysis in White, Black, and Asian ParticipantsShari R Lipner, Aditya K Gupta, Tracey C Vlahovic, et al.
Journal of Drugs in Dermatology : JDD|May 12, 2016
Onychomycosis: Does Cure Equate to Treatment Success?Boni E Elewski, Aditya K Gupta, Ted Rosen, et al.
The Journal of Clinical and Aesthetic Dermatology|July 28, 2016
Status Report from the Scientific Panel on Antibiotic Use in Dermatology of the American Acne and Rosacea Society: Part 1: Antibiotic Prescribing Patterns, Sources of Antibiotic Exposure, Antibiotic Consumption and Emergence of Antibiotic Resistance, Impact of Alterations in Antibiotic Prescribing, and Clinical Sequelae of Antibiotic UseJames Q Del Rosso, Guy F Webster, Ted Rosen, et al.
American Journal of Clinical Dermatology|September 13, 2021
Phase II, Double-Blind, Vehicle-Controlled Study to Determine the Cantharidin Dose Regimen, Efficacy, Safety, and Tolerability of VP-102 in Subjects with External Genital WartsScott Guenthner, Wendy McFalda, Melita Tate, et al.
The Journal of Clinical and Aesthetic Dermatology|July 8, 2016
Status Report from the Scientific Panel on Antibiotic Use in Dermatology of the American Acne and Rosacea Society: Part 3: Current Perspectives on Skin and Soft Tissue Infections with Emphasis on Methicillin-resistant Staphylococcus aureus, Commonly Encountered Scenarios when Antibiotic Use May Not Be Needed, and Concluding Remarks on Rational Use of Antibiotics in DermatologyJames Q Del Rosso, Ted Rosen, Diane Thiboutot, et al.
Journal of Drugs in Dermatology : JDD|October 7, 2020
Safety, Pharmacokinetics, and Efficacy of Efinaconazole 10% Topical Solution for Onychomycosis Treatment in Pediatric PatientsLawrence F Eichenfield, Boni Elewski, Jeffrey L Sugarman, et al.
Pageof 11